| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721682 | Diabetes & Metabolism | 2017 | 7 Pages |
Abstract
Over 12 months, Gla-300-treated participants achieved sustained glycaemic control and experienced less hypoglycaemia, particularly at night, versus Gla-100, supporting 6-month results.
Keywords
MMRMSAENPHLOCFFPGGLP-1OADANCOVAmITTTEAEmodified intent-to-treatstandard deviationinsulin glargineanalysis of covariancebaselinestandard errorType 2 diabetesbody mass indexBMIadverse eventSerious adverse eventconfidence intervalLOVFasting plasma glucoselast observation carried forwardNeutral protamine hagedornweekHypoglycaemiaglucagon-like peptide-1Least squaresGlycaemic control
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Y. Terauchi, M. Koyama, X. Cheng, M. Sumi, M.C. Riddle, G.B. Bolli, T. Hirose, EDITION JP 2 study group EDITION JP 2 study group,